RCE in Zkteco Zkbio Cvsecurity V5000
CVE-2024-6344
A vulnerability, which was classified as problematic, was found in ZKTeco ZKBio CVSecurity V5000 4.1.0. This affects an unknown part of the component Push Configuration Section. The manipulation of the argument Configuration Name leads to cross site scripting. It is possible to initiate the attack remotely. It is recommended to upgrade the affected component. The vendor explains, that "[s]ince ZKBio CVSecurity v5000 has been withdrawn from the market, we recommend upgrading to ZKBio CVSecurity V6600 6.1.3_R or above". This vulnerability only affects products that are no longer supported by the maintainer.
Vulnerability class: XSS (Cross-Site Scripting)
Published · last modified .
CVSS v3 metric
CVSS v3 base score 2.4 (Low). Vector: CVSS:3.1/AV:N/AC:L/PR:H/UI:R/S:U/C:N/I:L/A:N.
EPSS exploit prediction
EPSS: 0.004 (28.9th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 29th percentile — 28.9% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.004 · newest: 0.004 · change: 0.000
Affected products
- Zkteco Zkbio Cvsecurity V5000 — versions 4.1.0
- Zkteco Zkbiosecurity V5000 — versions 4.1.0
Weakness classification (CWE)
References
- vuldb.com/ (technical-description, VDB Entry, Third Party Advisory, vdb-entry)
- vuldb.com/ (signature, Permissions Required, permissions-required, VDB Entry)
- vuldb.com/ (VDB Entry, Third Party Advisory, third-party-advisory)
- www.zkteco.com/en/Security_Bulletinsibs/17 (related)
Frequently asked questions
- What is CVE-2024-6344?
- CVE-2024-6344 is a low-severity vulnerability in Zkteco Zkbio Cvsecurity V5000, classified under Cross-site Scripting. CVSS score: 2.4/10. Published 2024-06-26.
- How severe is CVE-2024-6344?
- Low severity. CVSS v3 base score is 2.4 out of 10.